IGC Pharma (IGC) Short Interest Ratio & Short Volume → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free IGC Stock Alerts $0.44 -0.02 (-4.36%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesOwnershipSEC FilingsShort Interest IGC Pharma Short Interest DataCurrent Short Volume938,800 sharesPrevious Short Volume848,500 sharesChange Vs. Previous Month+10.64%Dollar Volume Sold Short$0.00Short Interest Ratio / Days to Cover1.3Last Record DateMarch 31, 2024Outstanding Shares66,810,000 sharesPercentage of Shares Shorted1.41%Today's Trading Volume428,730 sharesAverage Trading Volume803,206 sharesToday's Volume Vs. Average53% Short Selling IGC Pharma ? Sign up to receive the latest short interest report for IGC Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIGC Short Interest Over TimeIGC Days to Cover Over TimeIGC Percentage of Float Shorted Over Time Ad American AlternativeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW IGC Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024938,800 shares $0.00 +10.6%N/A1.3 $0.00 3/15/2024848,500 shares $0.00 -6.8%N/A1.8 $0.00 2/29/2024910,700 shares $0.00 -1.7%N/A2.2 $0.00 2/15/2024926,300 shares $0.00 -3.6%N/A2.9 $0.00 1/31/2024961,300 shares $0.00 +13.8%N/A3.7 $0.00 1/15/2024844,800 shares $0.00 -3.9%N/A2.9 $0.00 Get the Latest News and Ratings for IGC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IGC Pharma and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023879,400 shares $0.00 -5.5%N/A3.5 $0.00 12/15/2023930,700 shares $0.00 -0.6%N/A3.9 $0.00 11/30/2023936,100 shares $0.00 +1.0%N/A4 $0.00 11/15/2023927,100 shares $0.00 -4.4%N/A3.6 $0.00 10/31/2023970,000 shares $0.00 +16.2%N/A3.9 $0.00 10/15/2023835,000 shares $0.00 +4.8%2.0%3.3 $0.00 9/30/2023796,900 shares $0.00 -10.1%1.9%3.8 $0.00 9/15/2023886,000 shares $387,447.80 +4.2%2.1%3.7 $0.44 8/31/2023850,600 shares $294,137.48 +7.0%2.1%4.1 $0.35 8/15/2023795,000 shares $0.00 -0.6%N/A4.8 $0.00 7/31/2023799,900 shares $0.00 -5.2%N/A4.7 $0.00 7/15/2023843,600 shares $0.00 -2.1%N/A5.4 $0.00 6/30/2023861,800 shares $0.00 -0.4%N/A5.7 $0.00 6/15/2023865,100 shares $0.00 -5.4%N/A8 $0.00 5/31/2023914,000 shares $0.00 +1.9%N/A8.2 $0.00 5/15/2023896,700 shares $0.00 -14.6%N/A8.8 $0.00 4/30/20231,050,000 shares $0.00 +12.2%2.4%9.8 $0.00 4/15/2023935,500 shares $0.00 +0.2%2.2%8 $0.00 3/31/2023933,500 shares $0.00 -1.1%2.2%7.6 $0.00 3/15/2023943,800 shares $0.00 +0.5%2.2%6 $0.00 2/28/2023939,100 shares $0.00 +5.4%2.2%5.8 $0.00 2/15/2023891,300 shares $0.00 +15.3%2.1%5.3 $0.00 1/31/2023773,200 shares $309,280.00 +0.3%1.8%4.4 $0.40 1/15/2023771,200 shares $0.00 -18.4%1.8%4.6 $0.00 12/30/2022945,100 shares $0.00 -2.8%2.2%5.7 $0.00 12/15/2022972,600 shares $0.00 -10.8%2.2%4.9 $0.00 11/30/20221,090,000 shares $0.00 -1.8%2.5%3.6 $0.00 11/15/20221,110,000 shares $0.00 +2.8%N/A3.8 $0.00 10/31/20221,080,000 shares $0.00 -1.8%N/A3.2 $0.00 10/15/20221,100,000 shares $0.00 +0.9%N/A3 $0.00 9/30/20221,090,000 shares $0.00 +0.9%N/A2.4 $0.00 9/15/20221,080,000 shares $0.00 +4.9%N/A2.7 $0.00 8/31/20221,030,000 shares $0.00 -3.7%N/A1.5 $0.00 8/15/20221,070,000 shares $0.00 -5.3%N/A1.5 $0.00Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW IGC Short Interest - Frequently Asked Questions What is IGC Pharma's current short interest? Short interest is the volume of IGC Pharma shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 938,800 shares of IGC short. Learn More on IGC Pharma's current short interest. What is a good short interest ratio for IGC Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IGC shares currently have a short interest ratio of 1.0. Learn More on IGC Pharma's short interest ratio. Is IGC Pharma's short interest increasing or decreasing? IGC Pharma saw a increase in short interest in March. As of March 31st, there was short interest totaling 938,800 shares, an increase of 10.6% from the previous total of 848,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does IGC Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to IGC Pharma: Theratechnologies Inc. (0.06%), Aprea Therapeutics, Inc. (2.35%), IntelGenx Technologies Corp. (0.04%), CASI Pharmaceuticals, Inc. (1.31%), Helix BioPharma Corp. (0.00%), Lexaria Bioscience Corp. (4.25%), JanOne Inc. (2.92%), Spruce Biosciences, Inc. (1.46%), Fortress Biotech, Inc. (14.08%), Viracta Therapeutics, Inc. (2.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short IGC Pharma stock? Short selling IGC is an investing strategy that aims to generate trading profit from IGC Pharma as its price is falling. IGC shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against IGC Pharma? A short squeeze for IGC Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IGC, which in turn drives the price of the stock up even further. How often is IGC Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IGC, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Theratechnologies Short Squeeze Aprea Therapeutics Short Squeeze IntelGenx Technologies Short Squeeze CASI Pharmaceuticals Short Squeeze Helix BioPharma Short Squeeze Lexaria Bioscience Short Squeeze JanOne Short Squeeze Spruce Biosciences Short Squeeze Fortress Biotech Short Squeeze Viracta Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSEAMERICAN:IGC) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders